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Nobox is an oocyte-speciﬁc transcriptional regulator. Nobox deﬁciency disrupts early folliculogene-
sis and the expression of oocyte-speciﬁc genes in mice. In the present study, we found that peptidyl-
arginine deiminase 6 (Pad6) was downregulated in Nobox-null ovaries. Pad6 is preferentially
expressed in oocytes and its transcript is detectable at embryonic day 16.5. In addition, we identiﬁed
one Nobox DNA-binding element (NBE) within the mouse Pad6 promoter. The NBE includes a core
sequence TAATTA. Sequence-speciﬁc binding of Nobox to the TAATTA motif was conﬁrmed. Nobox
overexpression augmented transcriptional activity of a luciferase reporter driven by mouse Pad6.
Our ﬁndings indicate that Nobox is a critical regulator that orchestrates oocyte-speciﬁc genes such
as Pad6 during folliculogenesis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nobox (Newborn ovary homeobox) is a germ cell-speciﬁc
homeobox domain-containing transcription factor critical for
early folliculogenesis [1,2]. Nobox transcripts are detectable as
early as E15.5 in embryonic ovaries and remain high in the
oocyte during folliculogenesis [1]. Nobox mRNA and protein are
preferentially expressed in oocytes of germ cell cysts and in pri-
mordial and growing oocytes throughout different stages of folli-
culogenesis [1,2]. Nobox deletion accelerates postnatal oocyte loss
and results in abnormal primordial and primary oocytes [1]. His-
tology of newborn ovaries in Nobox knockout and wild-type
mice is grossly similar, but differs signiﬁcantly at the molecular
level. Microarray analysis revealed numerous genes expressed
preferentially in the oocyte. For example, Pad6 was downregu-
lated in oocytes lacking Nobox (unpublished data). Recently we
found that Nobox binds preferentially to Nobox DNA-binding ele-
ments (NBE), TAA/GTTG/A, and increases the transcriptionalchemical Societies. Published by E
ical Science, CHA University,
46.activity of a luciferase reporter driven by a promoter containing
NBEs [3].
Peptidylarginine deiminases (PADs) are a family of enzymes
known to convert arginine to citrulline (Cit) in a calcium- and
DTT-dependent reaction [4]. To date, ﬁve PAD members have been
identiﬁed frommouse, rat, and human, PAD1, PAD2, PAD3, PAD4/5,
and PAD6. The PAD family members are approximately 50% iden-
tical at the amino acid level but they show tissue-speciﬁc expres-
sion [4]. In this study, we examined the relationship between
Pad6 expression and Nobox transcriptional regulation during
folliculogenesis.
2. Materials and methods
2.1. Tissue extract
Ovaries from wild-type and Nobox-null newborn mice were col-
lected as previously described [3]. Collected tissues were homoge-
nized in 100 ll of lysis buffer consisting of 20 mM HEPES (pH 7.9),
25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, and 0.2 mM EDTA.
Homogenized ovary tissues were incubated on ice for 30 min and
then centrifuged at 4 C for 30 min. After centrifugation, the super-
natant was transferred to new tubes. Samples were stored at
80 C until use.lsevier B.V. All rights reserved.
Fig. 1. Pad6 expression in tissues and embryonic ovaries. Total RNA from various
tissues (intestine, stomach, kidney, spleen, liver, heart, brain, lung, ovary, and testis)
and embryonic ovaries (at embryonic days 13.5, 14.5, 15.5, 16.5, 17.5, and 18.5) was
isolated and Pad6 mRNA was ampliﬁed using speciﬁc primers. (A) Pad6 is expressed
preferentially in the ovary. (B) Pad6 is detectable as early as embryonic day 17.5.
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The pET41b-Nobox homeodomain protein (GST-NXHD) was cre-
ated using a bacterial expression construct as follows: the homeo-
box domain of Nobox was ampliﬁed by PCR and cloned into the
pET41b vector. The sequence of the GST-NXHD fusion constructs
was veriﬁed to ensure that no mutations were introduced during
cloning. We transformed BL21-pLysS Escherichia coli (Stratagene)
with the GST-NXHD constructs and expressed them by inoculating
Luria–Bertani media containing 20 lg/ml of kanamycin in an over-
night culture (1:20 dilution) at 37 C to an OD600 of 0.5. Protein
expression was induced at 30 C with 2 mM of isopropyl-1-thio-
b-D-galactopyranoside to an OD600 of 1.0. The bacteria were lysed
using BugBuster lysis buffer (Novagen), and the GST-NXHD fusion
protein was puriﬁed by afﬁnity chromatography (Novagen).
2.3. Electrophoretic mobility shift assay (EMSA)
EMSAs were performed as previously described [3]. Reaction
mixtures were prepared to a ﬁnal concentration of 10 mM Tris,
pH 7.5, 50 mMNaCl, 1.5 mMMgCl2, 2.5 mM dithiothreitol, 5% glyc-
erol, 5 lg/ml poly(dI)–poly(dC), and 250 lg/ml bovine serum albu-
min. EMSA probes were prepared by end-ﬁlling annealed primers
with [a-32P]dCTP and Klenow polymerase (Invitrogen). Binding
reactions were conducted by incubating 32P-labeled probes
(250 000 cpm/reaction) with 50 ng of puriﬁed protein or 1 lg of
ovarian extract in the absence and presence of preimmune goat
serum or polyclonal anti-Nobox antibody. For the competition as-
say, puriﬁed proteins were incubated at room temperature with
cold competitors for 15 min before adding the 32P-labeled probe.
2.4. RT-PCR and quantitative RT-PCR
Total RNA was isolated using RNeasy mini kit (Qiagen). Two
micrograms of total RNA was reverse transcribed using the
Superscript system (Invitrogen). PCR was performed using
primers, 50-ACTCTTCTCGGACTGGCTGA-30 and 50-ACGTTCCCA-
TAGCCTTCCTT-30, that amplify a 165 bp product. PCR was carried
out using a program of 30 cycles at 94 C for 30 s (denaturation),
55 C for 30 s (annealing), and 72 C for 30 s (extension). Quantita-
tive real-time PCR was performed on the iQ-5 multicolor real-time
PCR Detection System (Bio-Rad) using iQ SYBR Green Supermix
(Bio-Rad). Each sample was analyzed in duplicate from at least
three independent wild-type and Nobox/ cDNA samples. The rel-
ative amount of transcripts was calculated using the DDCT method
and was normalized to an endogenous reference transcript, Gapdh.
One wild-type sample was randomly chosen to serve as the
reference sample to which all other samples were normalized.
The average and standard error were calculated for the triplicate
measurements, and the relative amount of target gene expression
for each sample was plotted. Statistical signiﬁcance was calculated
by the Student’s t-test using Microsoft Excel (Microsoft).
2.5. In situ hybridization
In situ hybridization was performed as previously described [1].
Brieﬂy, ovaries were waxed in 4% paraformaldehyde and embed-
ded in parafﬁn. Five-micrometer sections were hybridized to
35S-labeled sense and antisense riboprobes as described [1]. Signal
was detected by autoradiography using NTB-2 emulsion (Kodak)
and tissue was counterstained with hematoxylin.
2.6. Cell culture and reporter assays
Human embryonic kidney cells (HEK293) were grown in Dul-
becco’s modiﬁed Eagle’s medium supplemented with 10% fetal calfserum. For transient transfection, FuGENE6 (Roche Applied
Science) was used according to the manufacturer’s instructions.
Following the transfection, the cells were incubated for 48 h before
harvest. For each transfection, 200 ng of reporter construct, 200 ng
of the indicated expression plasmid, and 10 ng of pRT-TK normal-
ization plasmid were used per single well of a 6-well plate. Dual
luciferase assays were carried out with total cell extracts as recom-
mended by Promega. All transfection experiments were performed
in triplicate, and results were normalized to the expression of
Renilla luciferase.
3. Results
3.1. Pad6 expression in tissues and embryonic ovaries
We examined Pad6 expression in multiple tissues using RT-PCR.
Oligonucleotides speciﬁc for the Pad6 transcript ampliﬁed cDNAs
derived from tissues such as testes and ovaries (Fig. 1A). Pad6
mRNA was detected preferentially in adult ovaries (Fig. 1A). This
is consistent with a previous study that showed Pad6 expression
in oocytes and embryos [5,6].
To determine at which developmental time point Pad6 expres-
sion is initiated, RT-PCR was performed using total RNA isolated
from ovaries of mice at different embryonic stages, from embry-
onic day 13.5 to 18.5 (Fig. 1B). Pad6 transcripts were detected as
early as embryonic day 16.5 (Fig. 1B). Nobox mRNA was detected
as early as embryonic day 15.5, which was earlier than Pad6 [1].
This indicates that Nobox plays a role in regulating Pad6
expression.
The Pad family members are expressed in a tissue-speciﬁc man-
ner. Pad1 and Pad3 are expressed in the epidermis and hair follicles
[7–12]. Pad2 is the most widely distributed, with expression ob-
served in skeletal muscle, uterus, spinal cord, salivary glands, and
pancreas. Pad4 is expressed preferentially in white blood cells
[13–17].
We performed in situ hybridization to localize Pad6 transcripts
within the female gonads (Fig. 2). In 6-week-old wild type ovaries,
Pad6 mRNA expression was localized to oocytes from primordial
through antral follicles, but excluded from granulosa cells, theca
cells, and corpora lutea (Fig. 2B and D). Interestingly, this expres-
sion pattern is similar to that of Nobox [2], suggesting that Pad6
Fig. 2. Localization of Pad6 mRNA in wild-type and Nobox/ ovaries. Bright ﬁeld (A, C) and their corresponding dark ﬁeld (B, D) images of in situ hybridization are shown
with Pad6 riboprobe in 6-week-old ovaries. Oligonucleotides corresponding to Pad6 ampliﬁed RNA in wild-type ovaries. Pad6 localized to the primary follicle (PrF; arrows),
secondary follicle (SF; arrows), and growing follicle (TF; arrows).
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tion of Nobox.
3.2. Pad6 expression decreased in Nobox Nobox/ ovaries
We investigated the expression of Pad6 in wild-type and
Nobox/ newborn ovaries using in situ hybridization and quanti-
tative RT-PCR (Fig. 3). We chose newborn ovaries because the his-
tologies of these organs are grossly similar in wild type and
knockout animals despite their genetic differences [18]. Pad6 is
drastically downregulated in Nobox/ newborn ovaries (Fig. 3E).Fig. 3. The expression of Pad6 in Nobox/ ovaries. Bright ﬁeld (A, C) and their correspond
wild-type and Nobox/ newborn ovaries. Pad6 mRNA was detected in wild-type newbo
wild-type ovaries, Pad6 was expressed in germ cell cysts (GCC; arrows) and primordial f
ovaries by qPCR. Pad6 showed statistically signiﬁcant downregulation in mutant ovarieThis is consistent with the results of microarray data comparing
wild-type to Nobox-deﬁcient ovaries. Pad6 transcripts were de-
tected in germ cell cysts and primordial follicles in wild-type new-
born ovaries (Fig. 3B), but not in Nobox/ newborn ovaries
(Fig. 3D).
3.3. Nobox binds Nobox DNA-binding elements (NBEs) within the
mouse Pad6 promoter
We examined the promoter region of mouse Pad6 for the pres-
ence of NBEs (TAATTG, TAGTTG or TAATTA) [3]. The 1.5-kb mouseing dark ﬁeld (B, D) images of in situ hybridization are shown with Pad6 riboprobe in
rn ovaries (WT) but showed a dramatic decrease in Nobox/ ovaries. In newborn
ollicles (PF; arrows). (E) Quantitation of the relative expression of Pad6 in Nobox/
s (P > 0.05). The Student’s t-test was used to calculate P values. *P > 0.05.
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to the translational start site (+1)]. Interestingly, this putative NBE
contains six core sequences of TAATTA (Fig. 4A).
Next, we conﬁrmed interaction between the NBE and GST-
NXHD by EMSA. We chose an oligonucleotide consisting of an
NBE containing TAATTA. Using a competitive binding assay
(Fig. 4B), we assessed GST-NXHD binding to the NBE. We found
that DNA–protein complexes were out-competed by a 100-fold
molar excess of unlabeled putative NBE.
To verify whether endogenous Nobox protein binds directly to
this NBE, we performed an EMSA using protein extracts from new-
born mouse ovaries. Only wild-type ovarian extracts formed DNA–
protein complexes, which were conﬁrmed using an anti-mouse
Nobox antibody (Fig. 4C).
3.4. Nobox regulates the activity of mouse Pad6 promoter through the
NBE
To determine the effects of Nobox on the transactivation of
mouse Pad6, 293HEK cells were transiently transfected with con-
structs containing the wild-type (pPad6-Luc) or deleted promoter
(DpPad6-Luc). The 1.5-kb wild-type and 1.3-kb deleted Pad6 pro-
moters were cloned into constructs containing the luciferase repor-
ter gene driven by the NBE. Expression vectors without the NBE
were also generated. The wild-type or deleted constructs wereFig. 4. Nobox binds to the putative NBE within the Pad6 promoter. (A) The location of th
core sequence (TAATTA) at position-1433. (B) 32P-labeled NBE probes containing the N
(100) of unlabeled sequence was used as competitor. The arrow indicates the GST-NXH
bind the NBE. Gel mobility shift assay with ovarian extracts (wild-type and Nobox/ ne
wild-type ovarian extract (lanes 1–4), Nobox-null ovarian extract (lanes 5–8), no antisera
The arrow indicates the complex of Nobox and DNA fragment (BP), super-shifted compltransiently transfected along with the Nobox expression vector or
an empty vector (Mock) as a control. A Renilla luciferase expression
vector was used as an internal control for normalization of trans-
fection efﬁciency. The relative luciferase activities of the reporter
plasmids containing wild-type NBE or mutated NBE are shown in
Fig. 5. Nobox expression increased the activity of the Pad6 lucifer-
ase construct by fourfold (Fig. 5). This experiment suggests
that Pad6 is a candidate downstream target of Nobox during
folliculogenesis.
4. Discussion
In the present study, we observed that Pad6 is expressed prefer-
entially in the germ cell cyst, primordial follicle, and growing folli-
cles in the ovary. This observation is consistent with the fact that
Pad6 is highly abundant in oocytes and the early embryo [6]. Little
is known about the physiological function and regulatory mecha-
nism of Pad6 in the oocyte during folliculogenesis. Pad6 is one of
ﬁve members of the Pad family, which is involved in protein dei-
mination during development. Deimination of proteins is known
to affect protein folding and interaction by loss of intra- and inter-
molecular interactions or decrease in net positive charge. Histones
are known substrates of the Pad family [14,19,20]. Pad4 deiminates
histones H3 and H4 [20,21]. Keratin and ﬁlaggrin are PAD1 sub-
strates in epithelial cells [22,23]. Deimination of speciﬁc argininee Nobox DNA-binding element (NBE) within the Pad6 promoter. The NBE contains a
BE were incubated with puriﬁed recombinant GST-NXHD. A 100-fold molar excess
D–DNA complex (BP) and free probe (FP). (C) Wild-type newborn ovarian extracts
wborn mice) and 32P-labeled oligonucleotides containing the NBE with no extracts,
(lanes 1, 5), anti-Nobox antisera (lanes 3, 7), or preimmune goat serum (lanes 4, 8).
ex (SS), and free probe (FP).
Fig. 5. Nobox binds to the putative NBE within the Pad6 promoter. A vector expressing Nobox (Nobox) was co-transfected with either pPad6-Luc or deleted pPad6-Luc
(DpPad6-Luc) luciferase reporter vector into HEK293 cells. Empty vector (Mock) was used as a control. Cell extracts were harvested 48 h after transfection and analyzed for
luciferase activity. The black box indicates the wild-type promoter of pPad6 in the presence of TAATTA, and the white box indicates the deleted promoter of pPad6 in the
absence of the NBE.
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verting the preexisting ﬁne cytokeratin network to more densely-
bundled linear ﬁlamentous structures [24]. Substrates for Pad2
are vimentin in skeletal muscle and macrophages and myelin basic
protein in the central nervous system. The vimentin ﬁlament is a
highly dynamic structure that assembles and disassembles. Dei-
mination induces disassembly of vimentin ﬁlaments [25]. Pad6-
deﬁcient females are infertile due to failure of oocyte cytoskeletal
sheet formation during zygote development [26]. This suggests
that a substrate of Pad6 may be a cytoskeleton-related molecule.
Oogenesis is a highly dynamic process during early folliculogen-
esis. The germ cells begin with the breakdown of germ cell clusters
and formation of primordial follicles during embryonic develop-
ment. At the time of birth, some of the primordial follicles are
recruited to grow into growing follicles. During early folliculogene-
sis, transcription of numerous oocyte-speciﬁc genes, such as zona
pellucida, growth differentiation 9 (Gdf9), and Pou5f1 (known as
Oct4), commences [3,18]. The primary follicle continues growing
to the secondary and antral follicles. However, the regulatorymech-
anisms are poorly understood [27]. Recently, the physiological role
of oocyte-speciﬁc transcription regulators such as Nobox, Lhx8,
Sohlh1, and Sohlh2 have been characterized [1,3,28–30]. We will
further analyze each gene from the microarray data to understand
the regulatory networks in the oocyte during folliculogenesis.
In conclusion, we show that Nobox can bind the NBE, which is
present in the Pad6 promoter. These results suggest that Nobox
might regulate the expression of Pad6 directly. Functional
experiments with Nobox will be necessary to determine its speci-
ﬁcity on Pad6 regulation and its role in oocyte and germ cell
development.Acknowledgement
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